SEC Form 4/A · accession 0001445064-15-000175
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Matthew K Harbaugh
Officer — Sr. VP & CFO
Period of report
Dec 3, 2015
Accepted (ET)
Dec 7, 2015 · 1:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 3, 2015 | P | 260 | $74.046 | A | 46,055 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being amended to correct the previously reported transaction date.